Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

La Jolla Pharmaceutical Co

+ Add to Watchlist

LJPP:GR

18.711 EUR 0.371 1.94%

As of 09:08:04 ET on 01/30/2015.

Snapshot for La Jolla Pharmaceutical Co (LJPP)

Open: 19.293 Day's Range: 18.711 - 19.293 Volume: 0
Previous Close: 19.082 52wk Range: 5.224 - 20.061 1-Yr Rtn: -

Stock Chart for LJPP

No chart data available.
  • LJPP:GR 19.291
  • 1D
  • 1M
  • 1Y
19.082
Interactive LJPP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for LJPP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.7030
Est. PEG Ratio -
Market Cap (M EUR) 284.89
Shares Outstanding (M) 15.23
30 Day Average Volume 120
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for LJPP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for LJPP

La Jolla Pharmaceutical Company researches and develops specialized therapeutics for the treatment of diseases caused by antibodies. The Company is developing products to treat autoimmune conditions such as lupus and antibody-mediated stroke.

George F TidmarshPresident/CEO/SecretaryChester S Zygmont IIISenior Dir:Finance
James RolkeSenior Dir:Research & Dev
More Company Profile & Key Executives for LJPP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil